Seismic Therapeutic

Seismic Therapeutic is a biotechnology company integrating machine learning across the entire biologics discovery process to accelerate immunology drug development. Using its IMPACT™ platform, the company is addressing the central challenges of biologics discovery and development by fully integrating machine learning with the key elements of biologics drug discovery—structural biology, protein engineering, and translational immunology—to create optimized therapies on an accelerated path to patients. Seismic Therapeutic has a pipeline of biologics to address adaptive immune system dysregulation and treat autoimmune diseases.

Seismic Therapeutic headquartered in United States, North America, operates in the Biotechnology, Life Science, Health Care, Medical sector. The company focuses on Biotechnology and has secured $7.1B in funding across 32 round(s). With a team of 11-50 employees, Seismic Therapeutic is actively contributing to advancements in Biotechnology. Their latest funding round, Series B - Seismic Therapeutic, raised $121.0M. Discover more about their projects, partnerships, and impact on our platform.